Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Change in Inventory of $196000.0 for Q1 2026, up 133.33% year-over-year from $84000.0 in Q1 2025, and down 63.43% quarter-over-quarter from $536000.0 in Q4 2025.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Change in Inventory history runs 4 years deep, the most recent figure standing at $196000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 133.33% year-over-year to $196000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 55.12% YoY), while the FY2025 annual figure was $1.8 million, down 14.42% from the prior year.
- Change in Inventory for Q1 2026 stood at $196000.0, down from $536000.0 in the prior quarter.
- The five-year high for Change in Inventory was $3.1 million in Q4 2023, with the low at -$227000.0 in Q4 2024.
- The 4-year median for Change in Inventory is $536000.0 (2025), against an average of $645454.5.
- Peak annual rise in Change in Inventory reached 4246.67% in 2024, while the deepest fall reached 107.34% in 2024.
- Tarsus Pharmaceuticals' Change in Inventory stood at $3.1 million in 2023, then tumbled by 107.34% to -$227000.0 in 2024, then jumped by 336.12% to $536000.0 in 2025, then plunged by 63.43% to $196000.0 in 2026.
- Business Quant data shows TARS's Change in Inventory at $196000.0 in Q1 2026, $536000.0 in Q4 2025, and -$37000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Tarsus Pharmaceuticals | 3.96 Bn | 3.51 Bn | 161.80 Mn | -198,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -198,000.00 |
| Mar 31, 2026 | 196,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 84,000.00 |
| Dec 31, 2024 | -227,000.00 |
| Sep 30, 2024 | 652,000.00 |
| Jun 30, 2024 | 692,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | 15,000.00 |